{"hands_on_practices": [{"introduction": "Understanding the flow of ions through a channel is fundamental to neuroscience, and the current-voltage (I-V) relationship is our primary tool for this analysis. This exercise guides you through interpreting hypothetical patch-clamp data to determine the reversal potential ($E_{rev}$), a key biophysical fingerprint that reveals the net ion selectivity of the channel. By plotting current against voltage, you will learn to identify the membrane potential at which there is no net ion movement, a crucial step in characterizing any ion channel, including the nicotinic acetylcholine receptor (nAChR) [@problem_id:2346537].", "problem": "A neurobiologist is investigating a newly discovered synapse in the central nervous system. Using the whole-cell patch-clamp technique, the researcher records the electrical currents flowing through the postsynaptic membrane while holding the membrane potential at various fixed levels. After applying a saturating concentration of acetylcholine to activate all available postsynaptic nicotinic acetylcholine receptors (nAChR), the following steady-state current amplitudes are measured at different holding potentials. The data assumes that nAChRs are the only channels activated by this protocol and that their current-voltage relationship is linear in this range.\n\nThe experimental data are as follows:\n- At a holding potential of -70 mV, the measured current is -130 pA.\n- At a holding potential of -40 mV, the measured current is -70 pA.\n- At a holding potential of -10 mV, the measured current is -10 pA.\n- At a holding potential of +20 mV, the measured current is +50 pA.\n\nBased on this data, what is the reversal potential ($E_{rev}$) for these nAChR-mediated currents?\n\nA. -10 mV\n\nB. 0 mV\n\nC. -5 mV\n\nD. +5 mV\n\nE. -40 mV", "solution": "The current-voltage relationship for a population of identical ion channels that behave ohmically is linear and can be written as\n$$\nI = g\\,(V - E_{rev}),\n$$\nwhere $I$ is the current, $V$ is the membrane potential (holding potential), $g$ is the conductance (slope of the $I$-$V$ relation), and $E_{rev}$ is the reversal potential (the voltage at which $I=0$).\n\nUsing two data points, for example $(V_{1}, I_{1}) = (-10 \\text{ mV}, -10 \\text{ pA})$ and $(V_{2}, I_{2}) = (20 \\text{ mV}, 50 \\text{ pA})$, compute the slope (conductance):\n$$\ng = \\frac{I_{2} - I_{1}}{V_{2} - V_{1}} = \\frac{50 \\text{ pA} - (-10 \\text{ pA})}{20 \\text{ mV} - (-10 \\text{ mV})} = \\frac{60 \\text{ pA}}{30 \\text{ mV}} = 2 \\text{ pA/mV}.\n$$\nSubstitute $(V_{1}, I_{1})$ into the linear relation to solve for $E_{rev}$:\n$$\nI_{1} = g\\,(V_{1} - E_{rev}) \\;\\;\\Rightarrow\\;\\; -10 \\text{ pA} = 2 \\text{ pA/mV}\\,\\left(-10 \\text{ mV} - E_{rev}\\right).\n$$\nDivide both sides by $2 \\text{ pA/mV}$:\n$$\n-5 \\text{ mV} = -10 \\text{ mV} - E_{rev} \\;\\;\\Rightarrow\\;\\; E_{rev} = -10 \\text{ mV} + 5 \\text{ mV} = -5 \\text{ mV}.\n$$\nVerification with other points:\n- At $V=-40 \\text{ mV}$, $I = 2 \\text{ pA/mV}\\,(-40 \\text{ mV} - (-5 \\text{ mV})) = 2 \\times (-35) \\text{ pA} = -70 \\text{ pA}$, matches.\n- At $V=-70 \\text{ mV}$, $I = 2 \\times (-65) \\text{ pA} = -130 \\text{ pA}$, matches.\n\nTherefore, the reversal potential is $-5 \\text{ mV}$, corresponding to option C.", "answer": "$$\\boxed{C}$$", "id": "2346537"}, {"introduction": "Beyond its intrinsic properties, the function of an nAChR is powerfully influenced by pharmacological agents. This practice problem explores how to distinguish between two major classes of inhibitors: competitive and non-competitive antagonists, based on their distinct effects on the receptor's response to acetylcholine. By analyzing the results of a simulated experiment, you will develop the reasoning skills needed to deduce a drug's mechanism of action, a core skill in neuropharmacology [@problem_id:2346549].", "problem": "An electrophysiologist is investigating the properties of a specific subtype of nicotinic acetylcholine receptors (nAChRs) expressed on a cultured neuron. The experiment utilizes the whole-cell patch-clamp technique to measure the total inward ion current flowing through these channels when activated by their natural agonist, acetylcholine (ACh). The study aims to characterize the mechanism of two unknown pharmacological agents, Drug X and Drug Y.\n\nThe following observations are recorded:\n\n1.  **Control:** The application of a standard concentration, $C_{ACh}$, of acetylcholine to the neuron reliably induces a maximal inward current, denoted as $I_{max}$.\n2.  **Drug X Trial:** The neuron is first incubated with Drug X. When the standard concentration $C_{ACh}$ of acetylcholine is subsequently applied, the resulting inward current is significantly less than $I_{max}$. However, when the experiment is repeated with a much higher concentration of acetylcholine ($100 \\times C_{ACh}$), the measured inward current successfully recovers to the original maximal value, $I_{max}$. When applied alone, Drug X produces no measurable current.\n3.  **Drug Y Trial:** The neuron is first incubated with Drug Y. Similar to the previous trial, the application of the standard ACh concentration $C_{ACh}$ results in an inward current significantly less than $I_{max}$. In stark contrast to the trial with Drug X, even when the acetylcholine concentration is increased to $100 \\times C_{ACh}$, the inward current remains suppressed and does not recover to $I_{max}$. When applied alone, Drug Y also produces no measurable current.\n\nBased on these experimental results, which of the following statements most accurately describes the binding sites and mechanisms of action for Drug X and Drug Y?\n\nA. Drug X is a competitive antagonist that binds within the ion pore, while Drug Y is a non-competitive antagonist that binds to the ACh binding site.\n\nB. Drug X is a non-competitive antagonist that binds to the ACh binding site, while Drug Y is a competitive antagonist that binds within the ion pore.\n\nC. Drug X is a competitive antagonist that binds to the ACh binding site, while Drug Y is a non-competitive antagonist that likely acts as a pore blocker.\n\nD. Drug X and Drug Y are both competitive antagonists, but Drug Y has a much higher affinity for the ACh binding site.\n\nE. Drug X is a non-competitive antagonist that likely acts as a pore blocker, while Drug Y is a competitive antagonist that binds to the ACh binding site.", "solution": "We interpret the inward current through nicotinic acetylcholine receptors (nAChRs) under whole-cell patch clamp as a function of receptor activation by acetylcholine (ACh) and modulation by antagonists. Let $[A]$ denote the agonist (ACh) concentration, $I_{max}$ the maximal achievable current in control, and $I$ the measured current.\n\nFor competitive antagonism at the ACh binding (orthosteric) site, the standard receptor occupancy/dose-response relationship with a reversible antagonist $X$ at concentration $[X]$ and equilibrium dissociation constant $K_{X}$ is\n$$\nI([A],[X])=I_{max}\\,\\frac{[A]}{[A]+K_{A}\\left(1+\\frac{[X]}{K_{X}}\\right)},\n$$\nwhere $K_{A}$ is the agonist dissociation constant. This yields two characteristic predictions:\n- Surmountability: as $[A]\\to \\infty$, $I([A],[X])\\to I_{max}$ regardless of $[X]$, so the maximal response is recoverable at sufficiently high $[A]$.\n- No intrinsic efficacy: with $[A]=0$, $I(0,[X])=0$.\n\nFor non-competitive antagonism (e.g., channel pore blockade or negative allosteric modulation of efficacy), the antagonist reduces the effective maximal response without shifting the agonist $EC_{50}$ in a strictly competitive manner. A simple form capturing this is\n$$\nI([A],[Y])=\\alpha([Y])\\,I_{max}\\,\\frac{[A]}{[A]+K_{A}},\n$$\nwith $0<\\alpha([Y])<1$ determined by $[Y]$ and its binding constant. This is characterized by:\n- Insurmountability: even as $[A]\\to \\infty$, the current saturates at $\\alpha([Y])\\,I_{max}<I_{max}$, so increasing $[A]$ cannot restore $I_{max}$.\n- No intrinsic efficacy: with $[A]=0$, $I(0,[Y])=0$.\n\nNow match to observations:\n1. Control: $[A]=C_{ACh}$ produces $I_{max}$, consistent with $C_{ACh}$ near the saturating regime for this preparation.\n\n2. Drug X trial: At $[A]=C_{ACh}$, the current is less than $I_{max}$; however, raising $[A]$ to $100\\times C_{ACh}$ restores the current to $I_{max}$. This is the hallmark of surmountable antagonism, described by the competitive model above. Additionally, Drug X alone produces no current (no intrinsic efficacy), consistent with an antagonist. Therefore, Drug X is a competitive antagonist at the ACh binding site (orthosteric). Binding within the ion pore would not be competitive with ACh (since the pore and orthosteric sites are distinct) and typically yields insurmountable block.\n\n3. Drug Y trial: At $[A]=C_{ACh}$, current is reduced; even at $[A]=100\\times C_{ACh}$, the current remains suppressed and does not recover to $I_{max}$. This is the hallmark of insurmountable antagonism, well described by a non-competitive mechanism that reduces $I_{max}$, such as open-channel pore blockade or negative allosteric modulation of efficacy. Drug Y alone produces no current, consistent with antagonist behavior without agonism.\n\nEliminating distractors:\n- Statements placing a competitive antagonist in the ion pore (A and B) are inconsistent with the definition of competitive antagonism at the orthosteric ACh site.\n- Claiming both are competitive with Drug Y merely having higher affinity (D) is inconsistent with the observed insurmountability; even very high affinity competitive antagonism remains surmountable in principle by sufficiently high $[A]$.\n- Reversing the roles (E) contradicts the surmountability profile observed.\n\nTherefore, the correct description is that Drug X is a competitive antagonist at the ACh binding site, while Drug Y is a non-competitive antagonist likely acting as a pore blocker.\n\nHence, option C is correct.", "answer": "$$\\boxed{C}$$", "id": "2346549"}, {"introduction": "The elegant function of an ion channel arises directly from its molecular architecture. This problem delves into the structure-function relationship of the nAChR, focusing on how specific amino acids lining the ion pore dictate its behavior. Through a hypothetical mutagenesis experiment, you will apply the Goldman-Hodgkin-Katz (GHK) equation to predict how removing a ring of negatively charged residues affects both the channel's ion selectivity ($E_{rev}$) and its conductance, providing a powerful link between molecular detail and measurable electrophysiological properties [@problem_id:2346532].", "problem": "The muscle-type nicotinic acetylcholine receptor (nAChR) is a cation-selective ion channel crucial for neuromuscular transmission. Its pore is lined by several rings of charged amino acid residues that influence ion permeation. In the extracellular vestibule, there is a prominent ring of negatively charged residues (glutamate and aspartate). This ring creates a local negative electrostatic potential that attracts and concentrates permeant cations from the bulk extracellular solution.\n\nConsider a wild-type (WT) nAChR operating at a physiological temperature of $37^\\circ\\text{C}$. The electrostatic effect of the negative ring is such that the local concentration of any permeant monovalent cation at the channel mouth is $1.5$ times its concentration in the bulk extracellular solution.\n\nNow, imagine a genetic engineering experiment where all the residues in this negative ring are mutated to the neutral amino acid alanine. This mutation completely abolishes the local electrostatic concentrating effect.\n\nThe channel is permeable to both sodium (${\\text{Na}}^{+}$) and potassium (${\\text{K}}^{+}$) ions, with a relative permeability ratio of $P_{\\text{Na}}/P_{\\text{K}} = 1.2$. The ionic concentrations are as follows:\n- Extracellular: $[{\\text{Na}}^{+}]_{\\text{out}} = 145 \\text{ mM}$, $[{\\text{K}}^{+}]_{\\text{out}} = 4 \\text{ mM}$\n- Intracellular: $[{\\text{Na}}^{+}]_{\\text{in}} = 12 \\text{ mM}$, $[{\\text{K}}^{+}]_{\\text{in}} = 140 \\text{ mM}$\n\nAssume the intracellular concentrations and the relative permeability ratio are unaffected by the mutation. You are given the gas constant $R = 8.314 \\text{ J} \\cdot \\text{mol}^{-1} \\cdot \\text{K}^{-1}$ and the Faraday constant $F = 96485 \\text{ C} \\cdot \\text{mol}^{-1}$.\n\nWhich of the following statements best describes the changes observed in the mutant channel's properties compared to the wild-type channel?\n\nA. The reversal potential becomes more positive, and the single-channel conductance increases.\n\nB. The reversal potential becomes more positive, and the single-channel conductance decreases.\n\nC. The reversal potential becomes more negative, and the single-channel conductance increases.\n\nD. The reversal potential becomes more negative, and the single-channel conductance decreases.\n\nE. The reversal potential is unchanged, while the single-channel conductance decreases.", "solution": "We use two standard biophysical results.\n\nFirst, for a membrane channel permeable to multiple monovalent cations with relative permeabilities $P_{i}$, the Goldman-Hodgkin-Katz (GHK) reversal potential is\n$$\nE_{\\text{rev}}=\\frac{RT}{F}\\ln\\!\\left(\\frac{\\sum_{i}P_{i}\\,[i]_{\\text{out}}^{\\text{boundary}}}{\\sum_{i}P_{i}\\,[i]_{\\text{in}}}\\right),\n$$\nwhere $[i]_{\\text{out}}^{\\text{boundary}}$ denotes the concentration at the outer boundary of the permeation pathway (the channel mouth), and $[i]_{\\text{in}}$ is the bulk intracellular concentration.\n\nSecond, a fixed negative surface potential $\\psi_{\\text{out}}$ at the extracellular mouth produces a Boltzmann enhancement of the local monovalent cation concentration,\n$$\n[i]_{\\text{out}}^{\\text{boundary}}=[i]_{\\text{out}}\\exp\\!\\left(-\\frac{F\\psi_{\\text{out}}}{RT}\\right)\\equiv f\\,[i]_{\\text{out}},\n$$\nwith $f=\\exp\\!\\left(-\\frac{F\\psi_{\\text{out}}}{RT}\\right)$. The problem states that for the wild-type (WT) channel $f=1.5$ and that the alanine mutant abolishes this effect, so for the mutant $f=1$.\n\nApply these to the two-cation case ($\\text{Na}^{+}$ and $\\text{K}^{+}$). Let $P_{\\text{Na}}/P_{\\text{K}}$ be fixed and unchanged by mutation, and let bulk intracellular concentrations be unchanged.\n\nFor the WT,\n$$\nE_{\\text{rev}}^{\\text{WT}}=\\frac{RT}{F}\\ln\\!\\left(\\frac{P_{\\text{Na}}\\,f[\\text{Na}]_{\\text{out}}+P_{\\text{K}}\\,f[\\text{K}]_{\\text{out}}}{P_{\\text{Na}}[\\text{Na}]_{\\text{in}}+P_{\\text{K}}[\\text{K}]_{\\text{in}}}\\right)\n=\\frac{RT}{F}\\ln f+\\frac{RT}{F}\\ln\\!\\left(\\frac{P_{\\text{Na}}[\\text{Na}]_{\\text{out}}+P_{\\text{K}}[\\text{K}]_{\\text{out}}}{P_{\\text{Na}}[\\text{Na}]_{\\text{in}}+P_{\\text{K}}[\\text{K}]_{\\text{in}}}\\right).\n$$\nFor the mutant (no extracellular concentrating effect, $f=1$),\n$$\nE_{\\text{rev}}^{\\text{mut}}=\\frac{RT}{F}\\ln\\!\\left(\\frac{P_{\\text{Na}}[\\text{Na}]_{\\text{out}}+P_{\\text{K}}[\\text{K}]_{\\text{out}}}{P_{\\text{Na}}[\\text{Na}]_{\\text{in}}+P_{\\text{K}}[\\text{K}]_{\\text{in}}}\\right).\n$$\nTherefore,\n$$\nE_{\\text{rev}}^{\\text{WT}}-E_{\\text{rev}}^{\\text{mut}}=\\frac{RT}{F}\\ln f.\n$$\nBecause $f>1$, we have $\\ln f>0$, so $E_{\\text{rev}}^{\\text{WT}}>E_{\\text{rev}}^{\\text{mut}}$. Hence, when the negative ring is removed, the reversal potential becomes more negative relative to WT.\n\nNext, consider single-channel conductance. The GHK current equation for monovalent cations is\n$$\nI(V)=\\sum_{i}\\frac{P_{i}F^{2}}{RT}\\,V\\,\\frac{[i]_{\\text{out}}^{\\text{boundary}}-[i]_{\\text{in}}\\exp\\!\\left(-\\frac{FV}{RT}\\right)}{1-\\exp\\!\\left(-\\frac{FV}{RT}\\right)}.\n$$\nReplacing $[i]_{\\text{out}}^{\\text{boundary}}$ by $f[i]_{\\text{out}}$ shows that increasing $f$ increases the magnitude of the current for voltages where influx from outside contributes (particularly at negative voltages typical for inward currents through nAChRs). The slope conductance $g(V)=\\partial I/\\partial V$ is an increasing function of $[i]_{\\text{out}}^{\\text{boundary}}$; thus, removing the negative ring (setting $f$ from $1.5$ to $1$) decreases $[i]_{\\text{out}}^{\\text{boundary}}$ and therefore decreases the single-channel conductance. Equivalently, in access-resistance terms, the negative charges reduce the extracellular access resistance by increasing local ionic conductivity; their removal increases access resistance and lowers conductance.\n\nCombining both results: the mutation makes the reversal potential more negative and decreases the single-channel conductance. The correct choice is D.", "answer": "$$\\boxed{D}$$", "id": "2346532"}]}